Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy
Acute and chronic trigeminal (TG) neuropathies are the cause of considerable distress, with limited treatments available at present. Nociceptive neurons enriched with the vanilloid type 1 receptor (VR1) partake in pain sensation and sensitization in the TG system. While VR1 blockers with anti-nociceptive potential are of substantial medical interest, their use remains limited due to poor selectivity and lack of cell-targeting capabilities. This study describes a methodology for the alleviation of nociception via targeted depletion of VR1 in TG sensory neurons in rats. In cultured TG ganglion neurons, VR1 expression was virtually abolished by lentiviral short hairpin RNA (LV-VR1). By decorating GFP encoding LV (LV-GFP) and LV-VR1 with IgG192 for targeting TG sensory neurons enriched with the p75 neurotrophin receptor (p75NTR), transduction of a reporter GFP and VR1 depletion was achieved after injection of targeted vectors into the whisker pad. In IgG192/LV-VR1-injected rats, the behavioral response to capsaicin exposure as well as Erk 1/2 phosphorylation and VR1 current activation by capsaicin were significantly reduced. This pioneering investigation, thus, provides a proof of principle for a means of attenuating TG nociception, revealing therapeutic potential.
Keywordsp75NTR Capsaicin TRPV1 Neuropathic pain Neurotherapeutics
This work was supported by the Program for Research in Third Level Institutions Cycle 4 grant from the Republic of Ireland Higher Educational Authority for the neuroscience section of “targeted-driven therapeutics and theranostics” (JOD and SVO).
- 3.Fothergill, J., Of a painful affection of the face. Medical Observations and Inquiries. 5. 1773, Society of Physicians in London. 129–142.Google Scholar
- 9.Kandel Eric R., Schwartz J.H., Jessell Thomas M, Principles of Neural Science 2000: McGraw-Hill/Appleton & LangeGoogle Scholar
- 41.Wiffen, P.J., et al., Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev, 2011(1): p. CD005451.Google Scholar
- 43.Gronseth, G., et al., Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology, 2008. 71(15): p. 1183–90.CrossRefPubMedGoogle Scholar
- 49.Dunbar, C.E., et al., Gene therapy comes of age. Science 2018; 359(6372). https://doi.org/10.1126/science.aan4672.
- 54.Ovsepian S.V., O'Leary V.B., Ntziachristos V., Dolly J.O., Circumventing Brain Barriers: Nanovehicles for Retroaxonal Therapeutic Delivery. Trends Mol Med 2016;22:983–993.Google Scholar
- 62.Kacza, J., et al., Laser scanning and electron microscopic evidence for rapid and specific in vivo labelling of cholinergic neurons in the rat basal forebrain with fluorochromated antibodies. Brain Res, 2000. 867(1–2): p. 232–8.Google Scholar